| Aβ | Amyloid-β |
| AD | Alzheimer’s disease |
| AI | Autoimmune |
| AIE | Autoimmune Epilepsy |
| APOE | Apolipoprotein E |
| APP | Amyloid Precursor Protein |
| BACE1 | β-Secretase (Beta-Site APP-Cleaving Enzyme 1) |
| BBB | Blood–Brain Barrier |
| CNS | Central Nervous System |
| CSE | Convulsive Status Epilepticus |
| CSF | Cerebrospinal Fluid |
| DEEs | Developmental and Epileptic Encephalopathies |
| DRE | Drug Resistant Epilepsies |
| EEG | Electroencephalography |
| FBTCS | Focal to Bilateral Tonic–Clonic Seizure |
| FCD | Focal Cortical Dysplasia |
| FCD IIb | FCD Type IIb |
| GABA | Gamma-Aminobutyric Acid |
| GGE | Genetic General Epilepsy |
| GFAP | Glial Fibrillary Acidic Protein |
| GTCS | Generalized Tonic–Clonic Seizure |
| Hp-tau | Hyperphosphorylated Tau |
| HS | Hippocampal Sclerosis |
| IL-1 | Interleukin-1β |
| IL-6 | Interleukin-6 |
| IL-10 | Interleukin-10 |
| iPSC | Induced Pluripotent Stem Cells |
| ISF | Cerebral Interstitial Fluid |
| MRI | Magnetic Resonance Imaging |
| nSE | Non-Convulsive Status Epilepticus |
| Nf | Neurofilaments |
| NfH | Neurofilament Heavy Chain |
| NfL | Neurofilament Light Chain |
| NfM | Neurofilament Medium Chain |
| NFT | Neurofibrillary Tangle |
| PET | Positron Emission Tomography |
| PiB | Pittsburgh Compound B |
| PNES | Psychogenic Non-Epileptic Seizures |
| p-tau | Phosphorylated Tau |
| sAPPβ | Soluble Amyloid Precursor Protein Beta |
| SE | Status Epilepticus |
| sNfL | Serum Neurofilament Light Chain |
| TBI | Traumatic Brain Injury |
| TLE | Temporal Lobe Epilepsy |
| TNF-α | Tumor Necrosis Factor α |
| t-tau | Total tau |
| TSC | Tuberous Sclerosis Complex |
| UCH-L1 | Ubiquitin C-Terminal Hydrolase L1 |
| UPS | Ubiquitin–Proteasome System |